199 related articles for article (PubMed ID: 16310489)
1. The effect of subtenon triamcinolone acetonide injection for diabetic macular edema on retinal and choroidal circulation.
Mawatari Y; Koga T; Inumaru J; Hirata A; Fukushima M; Tanihara H
Am J Ophthalmol; 2005 Nov; 140(5):948-9. PubMed ID: 16310489
[TBL] [Abstract][Full Text] [Related]
2. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.
Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B; Sauder G
Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840
[TBL] [Abstract][Full Text] [Related]
3. Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema.
Ozdek S; Bahçeci UA; Gürelik G; Hasanreisoğlu B
J Diabetes Complications; 2006; 20(4):246-51. PubMed ID: 16798476
[TBL] [Abstract][Full Text] [Related]
4. Early treatment of severe cystoid macular edema in central retinal vein occlusion with posterior sub-tenon triamcinolone acetonide.
Lin JM; Chiu YT; Hung PT; Tsai YY
Retina; 2007 Feb; 27(2):180-9. PubMed ID: 17290200
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial.
Audren F; Erginay A; Haouchine B; Benosman R; Conrath J; Bergmann JF; Gaudric A; Massin P
Acta Ophthalmol Scand; 2006 Oct; 84(5):624-30. PubMed ID: 16965492
[TBL] [Abstract][Full Text] [Related]
6. Posterior sub-Tenon's capsule injection of triamcinolone acetonide prevents panretinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good vision.
Shimura M; Yasuda K; Shiono T
Ophthalmology; 2006 Mar; 113(3):381-7. PubMed ID: 16458970
[TBL] [Abstract][Full Text] [Related]
7. Intraocular pressure after intravitreal injection of triamcinolone acetonide following vitrectomy for macular edema.
Yamashita T; Uemura A; Kita H; Sakamoto T
J Glaucoma; 2007 Mar; 16(2):220-4. PubMed ID: 17473734
[TBL] [Abstract][Full Text] [Related]
8. Retinal vascular caliber changes after intravitreal triamcinolone treatment for diabetic macular edema.
Wickremasinghe SS; Rogers SL; Gillies MC; Zhu M; Wong TY
Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4707-11. PubMed ID: 18599569
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal triamcinolone acetonide for diffuse diabetic macular edema: phase 2 trial comparing 4 mg vs 2 mg.
Audren F; Lecleire-Collet A; Erginay A; Haouchine B; Benosman R; Bergmann JF; Gaudric A; Massin P
Am J Ophthalmol; 2006 Nov; 142(5):794-99. PubMed ID: 16978576
[TBL] [Abstract][Full Text] [Related]
10. Posterior juxtascleral infusion of modified triamcinolone acetonide formulation for refractory diabetic macular edema: one-year follow-up.
Veritti D; Lanzetta P; Perissin L; Bandello F
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2391-7. PubMed ID: 19117937
[TBL] [Abstract][Full Text] [Related]
11. Early effects of intravitreal triamcinolone on macular edema: mechanistic implication.
Miyamoto N; Iossifov D; Metge F; Behar-Cohen F
Ophthalmology; 2006 Nov; 113(11):2048-53. PubMed ID: 16935337
[TBL] [Abstract][Full Text] [Related]
12. [Triamcinolone in the treatment of the diabetic macular edema--one-year results].
Dusová J; Studnicka J; Rencová E; Korda V; Hejcmanová D
Cesk Slov Oftalmol; 2008 Jul; 64(4):149-52. PubMed ID: 18780654
[TBL] [Abstract][Full Text] [Related]
13. Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection.
Inoue M; Takeda K; Morita K; Yamada M; Tanigawara Y; Oguchi Y
Am J Ophthalmol; 2004 Dec; 138(6):1046-8. PubMed ID: 15629301
[TBL] [Abstract][Full Text] [Related]
14. Injection of triamcinolone acetonide into the posterior sub-tenon capsule for treatment of diabetic macular edema.
Toda J; Fukushima H; Kato S
Retina; 2007; 27(6):764-9. PubMed ID: 17621188
[TBL] [Abstract][Full Text] [Related]
15. Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema.
Salti H; Farah T
Am J Ophthalmol; 2005 Nov; 140(5):958; author reply 958-9. PubMed ID: 16310498
[No Abstract] [Full Text] [Related]
16. Short-term effects of intravitreal triamcinolone on retinal vascular leakage and trunk vessel diameters in diabetic macular oedema.
Vinten M; Larsen M; Lund-Andersen H; Sander B; La Cour M
Acta Ophthalmol Scand; 2007 Feb; 85(1):21-6. PubMed ID: 17244205
[TBL] [Abstract][Full Text] [Related]
17. Frequency and risk factors for intraocular pressure elevation after posterior sub-Tenon capsule triamcinolone acetonide injection.
Iwao K; Inatani M; Kawaji T; Koga T; Mawatari Y; Tanihara H
J Glaucoma; 2007 Mar; 16(2):251-6. PubMed ID: 17473740
[TBL] [Abstract][Full Text] [Related]
18. Laser photocoagulation combined with subtenon injection of triamcinolone acetonide for diabetic cystoid macular edema.
Kuo HK; Wu PC; Chen YH; Cheng LS
Chang Gung Med J; 2009; 32(2):172-81. PubMed ID: 19403007
[TBL] [Abstract][Full Text] [Related]
19. Comparative study on efficacy of a combination therapy of triamcinolone acetonide administration with and without vitrectomy for macular edema associated with branch retinal vein occlusion.
Hirano Y; Sakurai E; Yoshida M; Ogura Y
Ophthalmic Res; 2007; 39(4):207-12. PubMed ID: 17596753
[TBL] [Abstract][Full Text] [Related]
20. The transient efficacy of a single intravitreal triamcinolone acetonide injection for diabetic macular edema.
Desatnik H; Habot-Wilner Z; Alhalel A; Moroz I; Glovinsky J; Moisseiev J
Isr Med Assoc J; 2006 Jun; 8(6):383-7. PubMed ID: 16833165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]